• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chemical pathology of Huntington's disease.

作者信息

Bird E D

出版信息

Annu Rev Pharmacol Toxicol. 1980;20:533-51. doi: 10.1146/annurev.pa.20.040180.002533.

DOI:10.1146/annurev.pa.20.040180.002533
PMID:6446256
Abstract

Huntington's disease (HD), a dominantly inherited disorder of the nervous system, is usually manifest about middle age by dance-like movements. The disorder may occur in children, when epilepsy and rigidity may be the predominant signs. Degeneration of neurons occurs throughout the whole brain, but this is most marked in the basal ganglia. Neurochemical examination of postmortem brain frozen at the time of autopsy has been collected from patients dying with HD and compared with postmortem brain from psychotic patients and cases without neuropsychiatric disease. A number of alterations in neurotransmitters and their biosynthetic enzymes have been found. There are decreased concentrations of the neuroinhibitory transmitter gamma aminobutyric acid and this is associated with increased concentrations of dopamine and serotonin in the basal ganglia. In addition, there is decreased activity of glutamic acid decarboxylase, choline acetyltransferase, angiotensin-converting enzyme, as well as a decreased concentration of the neuropeptide substance P. Various pharmacologic agents have been tried based on the neurochemical alterations, but nothing has been found to be superior to the various neuroleptics in common use.

摘要

相似文献

1
Chemical pathology of Huntington's disease.
Annu Rev Pharmacol Toxicol. 1980;20:533-51. doi: 10.1146/annurev.pa.20.040180.002533.
2
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.在亨廷顿舞蹈病大鼠模型中,通过抑制内源性大麻素摄取减轻运动多动和神经化学缺陷。
Synapse. 2002 Apr;44(1):23-35. doi: 10.1002/syn.10054.
3
Neurochemical findings in Huntington's chorea.亨廷顿舞蹈病的神经化学研究结果
Essays Neurochem Neuropharmacol. 1977;1:177-95.
4
Huntington's disease: genetics, chemical pathology, and management.亨廷顿舞蹈症:遗传学、化学病理学及治疗
Prog Med Genet. 1985;6:91-122.
5
Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.亨廷顿舞蹈病患者苍白球中大麻素(CB(1))、γ-氨基丁酸A(GABA(A))和γ-氨基丁酸B(GABA(B))受体亚基的变化
J Chem Neuroanat. 2009 Jul;37(4):266-81. doi: 10.1016/j.jchemneu.2009.02.001. Epub 2009 Feb 21.
6
Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture.
Neurology. 1984 Aug;34(8):1059-72. doi: 10.1212/wnl.34.8.1059.
7
Huntington's chorea. Changes in neurotransmitter receptors in the brain.亨廷顿舞蹈症。大脑中神经递质受体的变化。
N Engl J Med. 1976 Jun 10;294(24):1305-9. doi: 10.1056/NEJM197606102942402.
8
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.
Nature. 1986;321(6066):168-71. doi: 10.1038/321168a0.
9
[Biochemical aspects of Huntington's disease].
Acta Cient Venez. 1977;28(6):391-7.
10
The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex.亨廷顿病的皮质病变:进一步的神经化学特征,以及大鼠皮质N-甲基-D-天冬氨酸损伤对某些组织学和神经化学特征的重现。
Ann Neurol. 1992 Oct;32(4):526-34. doi: 10.1002/ana.410320408.

引用本文的文献

1
TrkB signalling regulates dopamine circuits and motor function through metabolic pathways.TrkB信号通过代谢途径调节多巴胺回路和运动功能。
Nat Metab. 2024 Nov;6(11):2031-2032. doi: 10.1038/s42255-024-01154-0.
2
Impaired striatal glutathione-ascorbate metabolism induces transient dopamine increase and motor dysfunction.纹状体谷胱甘肽-抗坏血酸代谢受损导致多巴胺短暂增加和运动功能障碍。
Nat Metab. 2024 Nov;6(11):2100-2117. doi: 10.1038/s42255-024-01155-z. Epub 2024 Oct 28.
3
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes.
多巴胺在葡萄糖稳态调节、2型糖尿病发病机制及多巴胺活性/代谢受损的慢性病症中的作用:对病理生理及治疗目的的意义
Biomedicines. 2023 Nov 7;11(11):2993. doi: 10.3390/biomedicines11112993.
4
VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.VGLUT3 缺失可挽救亨廷顿病 zQ175 小鼠模型的运动缺陷和神经元丢失。
J Neurosci. 2023 Jun 7;43(23):4365-4377. doi: 10.1523/JNEUROSCI.0014-23.2023. Epub 2023 Apr 13.
5
Cortical and Striatal Circuits in Huntington's Disease.亨廷顿舞蹈病中的皮质与纹状体回路
Front Neurosci. 2020 Feb 6;14:82. doi: 10.3389/fnins.2020.00082. eCollection 2020.
6
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.抑制内源性大麻素降解可纠正亨廷顿病 Q175 小鼠模型中的动机和多巴胺能缺陷。
Neuropsychopharmacology. 2018 Sep;43(10):2056-2063. doi: 10.1038/s41386-018-0107-8. Epub 2018 Jun 1.
7
Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.纹状体神经递质在帕金森病和亨廷顿病发病机制中的新作用研究进展:综述。
Curr Neuropharmacol. 2019;17(2):165-175. doi: 10.2174/1570159X16666180302115032.
8
Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.多巴胺能奖赏编码受损伴随克服高努力成本意愿的抑制是亨廷顿舞蹈病Q175小鼠模型的一个突出前驱特征。
J Neurosci. 2016 May 4;36(18):4993-5002. doi: 10.1523/JNEUROSCI.0135-16.2016.
9
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease.增强的γ-氨基丁酸能输入导致亨廷顿舞蹈病R6/2小鼠模型中胆碱能中间神经元的功能改变。
eNeuro. 2015 Jan-Feb;2(1). doi: 10.1523/ENEURO.0008-14.2015.
10
Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model.普立哌啶,一种多巴胺稳定剂,可改善运动表现,并在亨廷顿病R6/2小鼠模型中显示出神经保护作用。
J Cell Mol Med. 2015 Nov;19(11):2540-8. doi: 10.1111/jcmm.12604. Epub 2015 Jun 22.